European drug watchdog backs Prozac for children
LONDON (Reuters) – Europe’s medicine watchdog said on
Tuesday that Prozac could be used to treat children aged eight
years and over.
Despite controversy over giving antidepressants to
adolescents, the European Medicines Agency said the benefits
outweighed the risks in children with moderate to severe
depression who failed to respond to psychological therapy.
Prozac, or fluoxetine, was originally developed by Eli
Lilly and Co but is now widely available in generic versions
since Lilly’s patent has expired.